Dagmar Kubitza

1PUBLICATIONS
0CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 11, 2022
Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study.

Dagmar Kubitza, Michael Heckmann, Jana Distler

Pageof 1

Frequent Collaborators